Prognostic value of the 6-min walk test derived attributes in patients with idiopathic pulmonary fibrosis

被引:2
|
作者
Bloem, Ada E. M. [1 ,2 ,3 ]
Dolk, Hanneke M. [2 ,3 ]
Wind, Anne E. [2 ,3 ]
van der Vis, Joanne J. [2 ,3 ,4 ]
Kampen, Maarten J. [2 ,3 ]
Custers, Jan W. H. [1 ]
Spruit, Martijn A. [5 ,6 ,7 ]
Veltkamp, Marcel [2 ,3 ,8 ]
机构
[1] Univ Appl Sci Utrecht, Inst Movement Studies, Fac Hlth Care, Utrecht, Netherlands
[2] St Antonius Hosp, Interstitial Lung Dis Ctr Excellence, Dept Pulmonol, Nieuwegein, Netherlands
[3] European Reference Network Lung, Nieuwegein, Netherlands
[4] St Antonius Hosp, Dept Clin Chem, Nieuwegein, Netherlands
[5] CIRO, Dept Res & Dev, Horn, Netherlands
[6] Maastricht Univ Med Ctr MUMC, Dept Resp Med, Maastricht, Netherlands
[7] Fac Hlth Med & Life Sci, NUTRIM, Inst Nutr & Translat Res Metab, Maastricht, Netherlands
[8] Univ Med Ctr Utrecht, Div Heart & Lungs, Utrecht, Netherlands
关键词
Idiopathic pulmonary fibrosis (IPF); 6-min walk test (6MWT); Functional exercise capacity; Prognostic; Physiotherapy; GAP (Gender-Age-Physiology) model; CLINICAL-PRACTICE; DISTANCE; SURVIVAL; STANDARDIZATION; PIRFENIDONE; MORTALITY; SOCIETY; UPDATE;
D O I
10.1016/j.rmed.2024.107862
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Idiopathic pulmonary fibrosis (IPF) is a fatal progressive fibrosing lung disease. A decreased 6-min walk distance (6MWD) and exercise-induced oxygen desaturation measured during the 6-min walk test (6MWT), are known predictors of mortality in patients with IPF. However, the use of antifibrotic drugs showed a survival benefit in IPF. Therefore, this study aimed to evaluate to what extend 6MWT-derived attributes are associated with two-year survival when antifibrotic drugs were introduced as part of standard IPF-care. Methods: This real-world data-study included patients with IPF with a 6MWT between 2015 and 2020, and used composite outcome: mortality or lung transplantation within 2 years of follow-up. Data were collected systematically, including demographics, pulmonary function tests, comorbidities, medications and 6MWT-derived attributes. The prediction attributes of 6MWT were studied with a Cox Proportional-Hazards model and Kaplan-Meier survival curves. The best discriminating attribute to predict mortality was added to the prediction model Gender-Age-Physiology (GAP). Results: In 216 patients, 2-year transplant-free survival cut-off points were identified for the 6MWD (>= 413 m), 6MWD %predicted (>= 83 %), SpO2-nadir (>= 86 %) and distance-saturation-product (>= 374 m%), with the best discriminative value for SpO2-nadir (area under the curve: 0.761). 2-Year survival percentage of patients with SpO2-nadir below or above threshold (86 %) was 37.1 % and 80.0 %, respectively. Exercise-induced oxygen desaturation added to the GAP model showed an improvement in its predictive power. Conclusion: Patients with IPF who have an exercise-induced oxygen desaturation have worse prognosis. Addition of SpO2-nadir to the GAP model seems promising for use in clinical care of IPF patients.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Impact of pulmonary hemodynamics on 6-min walk test in idiopathic pulmonary fibrosis
    Minai, Omar A.
    Santacruz, Jose F.
    Alster, Joan M.
    Budev, Marie M.
    McCarthy, K.
    RESPIRATORY MEDICINE, 2012, 106 (11) : 1613 - 1621
  • [2] Standardization of the 6-min walk test in clinical trials of idiopathic pulmonary fibrosis
    Lancaster, Lisa
    Fieuw, Ann
    Meulemans, Joyce
    Ford, Paul
    Nathan, Steven D.
    CONTEMPORARY CLINICAL TRIALS, 2021, 100
  • [3] Dyspnoea at 6-min walk test in idiopathic pulmonary fibrosis: Comparison with COPD
    Nishiyama, Osamu
    Taniguchi, Hiroyuki
    Kondoh, Yasuhiro
    Kimura, Tomoki
    Kato, Keisuke
    Ogawa, Tomoya
    Watanabe, Fumiko
    Arizono, Shinichi
    RESPIRATORY MEDICINE, 2007, 101 (04) : 833 - 838
  • [4] Heart Rate Recovery After 6-Min Walk Test Predicts Survival in Patients With Idiopathic Pulmonary Fibrosis
    Swigris, Jeffrey J.
    Swick, Jeff
    Wamboldt, Frederick S.
    Sprunger, David
    du Bois, Roland
    Fischer, Aryeh
    Cosgrove, Gregory P.
    Frankel, Stephen K.
    Fernandez-Perez, Evans R.
    Kervitsky, Dolly
    Brown, Kevin K.
    CHEST, 2009, 136 (03) : 841 - 848
  • [5] FVC variability in patients with idiopathic pulmonary fibrosis and role of 6-min walk test to predict further change
    Nathan, Steven D.
    Yang, Ming
    Morgenthien, Elizabeth A.
    Stauffer, John L.
    EUROPEAN RESPIRATORY JOURNAL, 2020, 55 (05)
  • [6] Prognostic value of 6-Min Walk Test (6MWT) in Patients with non-Idiopathic Pulmonary Fibrosis Progressive Fibrosing Interstitial Lung Disease (PF-ILD)
    Jeanniard, Gregoire
    Nasser, Mouhamad
    Turquier, Segolene
    Ahmad, Kais
    Lopez, Jesus Calabuig
    Glerant, Jean-Charles
    Traclet, Julie
    Chambellan, Arnaud
    Cottin, Vincent
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [7] The 6-min walk test: improving the prognostic power
    Ball, Karen L.
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2025, 328 (02): : H187 - H189
  • [8] Prognostic Indicators from 6 min Walk Test (6MWT) in Patients with Idiopathic Pulmonary Fibrosis (IPF)
    Alam, J.
    Tuder, C.
    Shahbaz, S.
    Moloney, E.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2011, 180 : S467 - S467
  • [9] Within-day test-retest reliability of the 6-min walk test in patients with pulmonary fibrosis
    Bloem, Ada E. M.
    Veltkamp, Marcel
    Custers, Jan W. H.
    Dolk, Hanneke M.
    Grutters, Jan C.
    Spruit, Martijn A.
    EUROPEAN RESPIRATORY JOURNAL, 2017, 49 (02)
  • [10] Prognostic value of 6-min walk test compared to cardiopulmonary exercise test in patients with severe heart failure
    Corra, Ugo
    Giordano, Andrea
    Marcassa, Claudio
    Gambarin, Fabiana Isabella
    Gnemmi, Marco
    Pistono, Massimo
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2022, 23 (06) : 379 - 386